Leuprorelin Acetate Depot 3M
Leuprorelin-4002
Approved small_molecule completed
Quick answer
Leuprorelin Acetate Depot 3M for Central Precocious Puberty is a Approved program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Central Precocious Puberty
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed